No Detail Found!

Diagnostic accuracy of serum prostate specific antigen and gleason score in determining the presence of skeletal metastasis in prostate cancer patients: a pakistani perspective

Author(s)
Taimoor Nasir FMC, Pakistan
Syeda Neha Aamer FMC, Pakistan
Saman Waqar Department of Paathology, Pakistan Institute of Medical Sciences, PIMS Islamabad, Pakistan
Wafa Omer Rawalpindi Medical University,Pakistan
Abstract
Objective: To determine the cut-off values for serum Prostate Specific Antigen (PSA) and Gleason score (GS) for predicting bone metastasis of Prostate cancer. Methodology: 330 Prostate cancer patients were enrolled in the study. PSA and GS were determined using commercially available ELECSYS® assays in Modular Analytics E170 (Roche Diagnostics) and histopathology respectively. Tc99m methylene diphosphonate (MDP) was used to perform the Bone scans (BS). Results: BS was positive in 186 (56.4%) patients and negative in 144 (43.6%) patients. Amongst these 186 positive patients, 5 (2.7%) had PSA < 20 ng/ml, and 181 (97.3%) had PSA > 20 ng/ml. Out of the 144 patients with negative BS, 142 (98.6%) had PSA < 20 ng/ml. Only 2 (1.4%) had PSA > 20 ng/ml. Of the 147 patients with PSA < 20 ng/ml, 142 (96.6%) did not have metastases. Of the 183 patients with PSA > 20 ng/ml, 181 (98.9%) had positive BS. Using a cut-off value of 20 ng/ml for PSA, 142 scans would have been unnecessary. Out of the 186 patients with positive BS, 3 (1.6%) patients had GS < 7, and 183 (98.4%) had GS > 7. Out of the 144 patients with negative BS, 84 (58.3%) had GS < 7, and 60 had GS > 7. Of the 87 patients with GS < 7, 3 (3.4%) patients had a positive BS while 84 (96.6%) patients had a negative BS. Of the 243 patients with GS > 7, 183 (75.3%) had a positive BS while 60 (24.7%) patients had a negative GS. This indicates that a GS > 7 cannot be reliably used to rule in the need for a BS in Prostate cancer patients. Conclusion: Our study concludes that serum PSA < 20 ng/ml can be safely used to omit a BS. It suggests that Gleason Score < 7 nullifies the need to conduct a BS. However, serum PSA is a more reliable indicator of bone metastases because of better sensitivity and specificity.
Publication Details
Page(s) 220-224
Published Journal: Journal of Rawalpindi Medical College, Volume: 27, Issue: 1, Year: 2023

Request the full text from PASTIC

Keywords
gleason score, Bone metastasis, Prostate cancer, bone scan, prostate-specific antigen.
0

Citations

0

Downloads

81

Views